> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Docket Established for Pediatric Postmarketing Reviews
- URL: https://www.fdaweb.com/docket-established-for-pediatric-postmarketing-reviews/
- Published: 2017-02-21T12:00:00.000Z
- Updated: 2026-09-14T22:07:44.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138027

*Federal Register* Notice: FDA has established a public docket to collect comments related to pediatric postmarketing pharmacovigilance and drug utilization reviews of products posted between 9/17/2016 and 2/24/2017 on the agency’s Web site, but will not be presented at a 3/6-7 Pediatric Advisory Committee (PAC) meeting. These reviews are intended to be available for review and comment by members of the PAC, interested parties (such as academic researchers, regulated industries, consortia, and patient groups), and the general public. To view the reviews, click [here](https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/ucm510701.htm?ref=fdaweb.com). To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-02-21/pdf/2017-03365.pdf?ref=fdaweb.com).